Ship AI agents without rewriting 20 years of bash scripts
Automatically transpile your legacy CLI tools and shell scripts into agent-safe, structured interfaces with runtime sandboxing—no manual rewrites needed. Deploy autonomous agents across your existing DevOps infrastructure in days, not quarters, while maintaining security through gVisor isolation and observability through real-time execution monitoring. Bridge the gap between your battle-tested tooling and the AI-native future without throwing away institutional knowledge embedded in thousands of scripts.
Key Benefits:
- Automatic transpilation of bash/Python/Ruby scripts into structured JSON schemas that AI agents can reliably invoke, eliminating manual interface documentation
- Runtime safety sandbox using gVisor and seccomp filters that prevents agents from executing dangerous commands while maintaining compatibility with existing tool behavior
- Drop-in compatibility layer that preserves your existing CLI tool semantics while exposing agent-friendly interfaces, protecting years of operational knowledge
MVP Scope: Build automated transpilation pipeline to convert legacy CLI tools into structured agent-compatible interfaces with JSON schemas. Include runtime sandboxing for safe execution, basic tool scanning for 3-5 common CLI patterns, and a web dashboard for monitoring transpiled tool execution.
Tech Stack: LLVM/Ghidra, tree-sitter, WebAssembly, gVisor/seccomp, FastAPI, PostgreSQL, Prometheus
Components:
- Legacy Tool Scanner & Parser
- AI-Agent Interface Transpiler
- Runtime Safety Sandbox
- Agent Orchestration Layer
- Monitoring & Observability Dashboard
Quality assessment: Strong technical concept addressing a real pain point (legacy tool integration with AI agents) with concrete architecture and appropriate tech stack, but lacks implementation depth, specific use cases, and evidence of market validation—falls short of 0.90+ due to incomplete pitch and missing technical details on the transpilation approach.
Comments
Sign in to join the conversation.
No comments yet. Be the first to share your thoughts.